Is Early Response to Chemotherapy a Useful Prognostic Factor in Adult Acute Lymphoblastic Leukemia

  • C. Sebban
  • E. Lepage
  • P. Dufour
  • F. Huguet
  • F. Witz
  • A. Broustet
  • B. Pignon
  • X. Troussard
  • M. Flesh
  • C. Cordonnier
  • D. Fiere
  • The French Group for Therapy of Adult Acute Lymphoblastic Leukemia
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 36)

Abstract

In order to assess the eventual prognostic significance of early response to chemotherapy in adult acute lymphoblastic leukemia (ALL), we recommended to perform a bone marrow aspiration at day 15 after the beginning of the induction, in the last two French multicentric trials: AALL85 and AALL87.

Keywords

Leukemia Anemia Oncol Cyclophosphamide Stein 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Preisler H, Barcos M, Reese P et al. (1983) Prediction of response of acute nonlymphocytic leukaemia: utility of day 6 bone marrow biopsy. Leuk Res 7, 1: 67–75PubMedCrossRefGoogle Scholar
  2. 2.
    Archimbaud E, Treille-Ritouet D, Guyotat D et al. (1987) Day 4 bone marrow aspirate for prediction of resistance to induction chemotherapy in acute myeloid leukaemia. Leuk Res 11, 3: 281–283PubMedCrossRefGoogle Scholar
  3. 3.
    Peters WG, Willemze R, Colly LP et al. (1985) Prediction of response of acute nonlymphocytic to therapy with “high dose” cytosine arabinoside. Br J Haematol 59: 733–734PubMedCrossRefGoogle Scholar
  4. 4.
    Browman G, Preisler H, Raza A, Syracuse K, Azarnia N, Benger A, Chervenick P, D’Arrigo P, Doeblin T, Golberg J, Gottlieb A, Grunwald H, Kirshner J, Larson R, Meyer R, Miller K, Priore R, Stein M, Vogler R, Walker I, Wilson EC and Barcos M (1989) Use of the day 6 bone marrow to alter remission induction therapy in patients with acute myeloid leukaemia: a leukemia intergroup study. Br J Haemat 71: 493–497CrossRefGoogle Scholar
  5. 5.
    Jacquillat C, Weil F, Germon MF et al. (1973) Combination therapy in 130 patients with acute lymphoblastic leukemia. Cancer Res 33: 3278–3284PubMedGoogle Scholar
  6. 6.
    Miller DR, Leikin S, Albo V et al. (1980) Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children’s Cancer Study Group Report. Cancer Treat Rep 64: 381–392PubMedGoogle Scholar
  7. 7.
    Rautonen J, Hovi L and Siimes MA (1988) Slow disappearance of peripheral blast cells: an independent risk factor indicating poor prognosis in children with acute lymphoblastic leukemia. Blood 71: 989–991PubMedGoogle Scholar
  8. 8.
    Frei E and Sallan SE (1978) Acute lymphoblastic leukemia: treatment. Cancer 42: 828–838PubMedCrossRefGoogle Scholar
  9. 9.
    Miller DR, Coccia PF, Bleyer W A et al. (1989) Early response to induction therapy as apredictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. J Clin Oncol 7: 1807–1815PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • C. Sebban
    • 1
  • E. Lepage
    • 1
  • P. Dufour
    • 1
  • F. Huguet
    • 1
  • F. Witz
    • 1
  • A. Broustet
    • 1
  • B. Pignon
    • 1
  • X. Troussard
    • 1
  • M. Flesh
    • 1
  • C. Cordonnier
    • 1
  • D. Fiere
    • 1
  • The French Group for Therapy of Adult Acute Lymphoblastic Leukemia
    • 1
  1. 1.Service d’bématologieHopital Edouard HerriotLyonFrance

Personalised recommendations